We report a case of trans-sternal thymectomy for myasthenia gravis using a non relaxant, total intravenous technique with propofol and remifentanil. This afforded excellent control of heart rate and pressor responses during surgery while allowing early return of spontaneous ventilation and extubation within nine minutes of termination of anaesthesia. Advantages and disadvantages of this approach versus relaxant and volatile techniques are discussed with particular reference to preservation of neuromuscular function.
The provision of general anaesthesia for transsternal thymectomy in myasthenia gravis has traditionally been complicated by a variable increased sensitivity in this group to the action of neuromuscular blocking agents 1, 2, 3 . This can be compounded by significant reduction in neuromuscular function with the use of volatile anaesthetic agents 4 . In addition, depression of central respiratory drive from co-administered intraoperative opioids can further compromise respiratory function in the immediate postoperative period.
We report a case of trans-sternal thymectomy under general anaesthesia with the use of a total intravenous technique using propofol and the ultra short acting µ receptor agonist remifentanil.
CASE REPORT
A 17-year-old 60kg female with a five-month history of myasthenia gravis was scheduled for transsternal thymectomy. Clinically her symptoms correlated with an Osserman classification 5 of IIa (Table 1) with her principal complaints consisting of proximal limb muscle weakness with relative sparing of bulbar function; specifically no difficulty swallowing or clearing saliva. On examination she had bilateral ptosis which increased with fatigue, diplopia on extreme upward gaze and proximal limb weakness, also demonstrating fatigue. Palatal and tongue movements were normal with no difficulty swallowing water. Her preoperative treatment consisted of pyridostigmine 60 mg 6 hourly. This gave tolerable symptomatic relief but with persisting mild proximal limb weakness. Higher dose anticholinesterase therapy had caused unacceptable side-effects of crampy abdominal pain and diarrhoea. In view of the relative stability of symptoms and early presentation for surgery, immunosuppressive therapy had not been embarked upon. There was no evidence of additional co-existing autoimmune disease.
Diagnosis had been established on the basis of the clinical picture, a positive edrophonium test (transient improvement in muscle strength after intravenous edrophonium 2 mg) and elevated acetylcholine receptor antibodies at >8 nmol/l (normal up to 0.25 nmol/l, positive >0.4 nmol/l). The thymus gland appeared normal on computerized axial tomography. Her respiratory function was stable with preoperative spirometry as follows; FVC of 3.14 litres (predicted 3.49), FEV1 1.71 litres (predicted 3.34), FEV1/FVC 54% (96%) and peak flow of 204 litres/ minute (predicted 434 litres/minute). The patient was self medicating and continued with pyridostigmine 60 mg six-hourly without omission up to surgery.
Premedication consisted of oral metoclopramide 20 mg, promethazine 10 mg and famotidine 40 mg with oxygen 3 litres/minute by nasal prongs. Under local anaesthesia in the operating theatre a 14 gauge intravenous cannula and an 18 gauge arterial line were sited along with monitoring in accordance with the Australian and New Zealand College of Anaesthetists guidelines 6 . After preoxygenation, anaesthesia was commenced by infusing simultaneously propofol 4 mg/kg/hour and remifentanil 1 µg/kg/minute. After three minutes a bolus of 90 mg (1.5 mg/kg) of propofol was given. The trachea was intubated after a further minute. Intubating conditions as assessed according to Young 7 were; jaw relaxation-good, cord relaxation-fair and reaction to intubation-slight.
Anaesthesia was continued with infusions of propofol 4 mg/kg/hour and remifentanil 1 µg/kg/ minute, intermittent positive pressure ventilation and an FiO 2 of 0.4 (air/oxygen). A nasogastric tube and nasal temperature probe were sited and the patient kept warm using a lower body convection heater and heated water mattress. Five minutes after intubation morphine 6 mg and cephradine 1g were given by intravenous bolus. Figure 1 shows the continuous arterial pressure and pulse tracings and Table 2 shows the timing of intraoperative events. Significantly there were no changes in pulse rate or blood pressure to intubation, skin incision or sternotomy.
Normothermia and normocapnia were maintained throughout the procedure which lasted 95 minutes. After 45 minutes the remifentanil infusion was reduced to 0.5 µg/kg/minute and during skin suturing (90 minutes) the propofol rate reduced to 2 mg/kg/hour. At the end of the procedure both infusions were stopped and spontaneous respiration commenced after three minutes. The patient was extubated in the theatre six minutes later when it was apparent that the endotracheal tube was not being tolerated and sustained head-lift was possible (>5 seconds). At this point the end-expiratory carbon dioxide concentration (PECO 2 ) was 6.5 kPa. The patient was subsequently transferred to the intensive care unit for continued observation.
Postoperative analgesia was provided in the form of patient-controlled intravenous morphine (1 mg bolus, 5 minute lockout, 4 hour limit 30 mg), paracetamol 1g 4 hourly and tenoxicam 20 mg nocte. Pyridostigmine was recommenced at 60 mg 8 hourly. Arterial blood gas monitoring was performed at 2, 6 and 14 hours after the procedure with the patient on oxygen 2 l/minute via nasal prongs (see Table 2 ). After 14 hours the patient was judged suitable for transfer to the open ward on oxygen 2 l/minute. Recovery was otherwise unremarkable.
DISCUSSION
The increased sensitivity of myasthenic patients to the action of a variety of nondepolarizing neuromuscular blocking agents has been well documented in the literature 1, 2, 3, 8 . Similarly the increased potency of the neuromuscular blocking properties of volatile anaesthetics has been noted, with Nilsson suggesting that in the case of isoflurane the presence of acetylcholine receptor antibodies and the HLA-B8 genotype may predict a more susceptible subgroup 9 the safe inclusion of both these groups of drugs in myasthenia gravis has been demonstrated, including non-relaxant techniques 10 , neuromuscular transmission may be depressed as a direct result of their use.
In addition the use of anticholinergic agents in reversing neuromuscular blockade raises the possibility of inducing cholinergic crisis 11 . The use of total intravenous anaesthesia (TIVA) appears to avoid both these hazards as has previously been reported 12 .
However we are unaware of any previous reports of the combination of remifentanil and propofol in this respect.
With the place of propofol in TIVA well established, the introduction of remifentanil appears to offer an ideal companion for minimum impact at the neuromuscular junction and precise control of depth and duration of balanced anaesthesia. The properties that promote its use in this setting are its potent µ receptor agonism, short half-life of eight to ten minutes (including a context sensitive half-life of four minutes) and metabolism by non-specific esterases which in myasthenia gravis allows anticholinesterase medication to be continued throughout the perioperative phase 13 . These characteristics allow for impressive intraoperative control of cardiovascular responses to noxious stimuli such as intubation and sternotomy while achieving rapid emergence and return of spontaneous ventilation. Our case illustrates just such features with no significant rate or pressor responses during maintenance of anaesthesia, while spontaneous respiration commenced three minutes after cessation of the infusion with extubation after nine minutes. These times compare well with published data in subjects with normal neuromuscular function 14 .
The use of such a "rapid offset" opioid does however require adequate provision of postoperative analgesia. The addition of a modest dose of a longeracting opioid in anticipation of ongoing analgesic requirements in our case does not appear to have delayed return of ventilation, although it may have contributed to the modest postoperative hypoventilation as demonstrated by the blood gas values and the PECO 2 .
While the use of a combined remifentanil/propofol total intravenous technique might avoid many pitfalls associated with anaesthesia in the myasthenic patient, it still requires attention to detail, particularly with respect to immediate postoperative pain relief. Nevertheless we have been able to demonstrate that in this case the technique offered both excellent intraoperative conditions and early extubation.
